Federal Circuit OKs PTAB Rejection Of Heart Valve Patent Invalidity Arguments
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel affirmed a U.S. Patent Trial and Appeal Board (PTAB) order that allowed Cardiovalve Ltd. to amend multiple claims in its...To view the full article, register now.
Already a subscriber? Click here to view full article